CureVac N.V. (FRA:5CV)
3.844
-0.026 (-0.67%)
Jun 6, 2025, 5:10 PM CET
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
€579,314
Profits / Employee
€199,840
Market Cap
871.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 90,587 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 24,363 |
CureVac News
- 17 days ago - CureVac BV reports Q1 results - Seeking Alpha
- 17 days ago - CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates - Wallstreet:Online
- 17 days ago - CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates - Accesswire
- 17 days ago - CureVac Unveils Q1 2025 Financial Results & Business Updates! - Wallstreet:Online
- 17 days ago - EQS-News: CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates - Wallstreet:Online
- 22 days ago - CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE - Wallstreet:Online
- 22 days ago - CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE - Accesswire
- 4 weeks ago - BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion - Benzinga